A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Novo Nordisk A S stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 43,260 shares of NVO stock, worth $4.56 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
43,260
Previous 40,001 8.15%
Holding current value
$4.56 Million
Previous $5.71 Million 9.79%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $388,049 - $473,923
3,259 Added 8.15%
43,260 $5.15 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $1.33 Million - $1.6 Million
-10,868 Reduced 21.36%
40,001 $5.71 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $5.19 Million - $6.91 Million
50,869 New
50,869 $6.53 Billion
Q4 2023

Aug 14, 2024

BUY
$87.78 - $105.45 $399,925 - $480,430
4,556 Added 15.48%
33,989 $3.52 Billion
Q3 2023

Aug 14, 2024

SELL
$90.94 - $199.54 $3.11 Million - $6.83 Million
-34,232 Reduced 53.77%
29,433 $2.68 Billion
Q2 2023

Aug 14, 2024

BUY
$155.98 - $172.65 $483,070 - $534,697
3,097 Added 5.11%
63,665 $10.3 Billion
Q1 2023

Aug 14, 2024

BUY
$132.34 - $159.14 $185,408 - $222,955
1,401 Added 2.37%
60,568 $9.64 Billion
Q4 2022

Aug 14, 2024

BUY
$102.55 - $135.33 $543,207 - $716,843
5,297 Added 9.83%
59,167 $8.01 Billion
Q3 2022

Aug 14, 2024

BUY
$95.28 - $116.93 $4.12 Million - $5.05 Million
43,228 Added 406.2%
53,870 $5.37 Billion
Q2 2022

Aug 14, 2024

SELL
$103.24 - $121.81 $192,542 - $227,175
-1,865 Reduced 14.91%
10,642 $1.19 Billion
Q1 2022

Aug 14, 2024

SELL
$93.1 - $112.54 $2.56 Million - $3.09 Million
-27,494 Reduced 68.73%
12,507 $1.39 Billion
Q4 2021

Aug 30, 2024

SELL
$95.88 - $117.08 $182,363 - $222,686
-1,902 Reduced 12.9%
12,842 $1.44 Billion
Q3 2021

Aug 30, 2024

SELL
$84.42 - $106.62 $392,806 - $496,102
-4,653 Reduced 23.99%
14,744 $1.42 Billion
Q2 2021

Aug 30, 2024

SELL
$67.66 - $84.76 $1.39 Million - $1.75 Million
-20,604 Reduced 51.51%
19,397 $1.62 Billion
Q1 2021

Aug 30, 2024

SELL
$67.06 - $75.82 $124,865 - $141,176
-1,862 Reduced 6.48%
26,868 $1.81 Billion
Q4 2020

Aug 30, 2024

SELL
$63.89 - $73.8 $91,682 - $105,903
-1,435 Reduced 4.76%
28,730 $2.01 Billion
Q3 2020

Aug 30, 2024

SELL
$63.69 - $70.22 $428,952 - $472,931
-6,735 Reduced 18.25%
30,165 $2.09 Billion
Q2 2020

Aug 30, 2024

SELL
$58.54 - $67.94 $2.17 Million - $2.52 Million
-37,030 Reduced 50.09%
36,900 $2.42 Billion
Q1 2020

Aug 30, 2024

SELL
$49.46 - $64.78 $4.08 Million - $5.34 Million
-82,484 Reduced 52.73%
73,930 $4.45 Billion
Q4 2019

Aug 30, 2024

SELL
$49.86 - $58.26 $434,629 - $507,852
-8,717 Reduced 5.28%
156,414 $9.05 Billion
Q3 2019

Aug 30, 2024

BUY
$47.54 - $53.43 $132,826 - $149,283
2,794 Added 1.72%
165,131 $8.54 Billion
Q2 2019

Aug 30, 2024

BUY
$46.79 - $52.47 $273,347 - $306,529
5,842 Added 3.73%
162,337 $8.29 Billion
Q1 2019

Aug 30, 2024

SELL
$46.36 - $52.63 $27,120 - $30,788
-585 Reduced 0.37%
156,495 $8.19 Billion
Q4 2018

Aug 30, 2024

BUY
$41.54 - $47.25 $4.86 Million - $5.53 Million
117,079 Added 292.69%
157,080 $7.24 Billion
Q3 2018

Aug 30, 2024

BUY
$46.76 - $51.24 $81,035 - $88,798
1,733 Added 1.2%
146,444 $6.9 Billion
Q2 2018

Aug 30, 2024

SELL
$44.29 - $50.42 $22,233 - $25,310
-502 Reduced 0.35%
144,711 $6.67 Billion
Q1 2018

Aug 30, 2024

BUY
$48.49 - $58.14 $280,272 - $336,049
5,780 Added 4.15%
145,213 $7.15 Billion
Q4 2017

Aug 30, 2024

SELL
$47.53 - $53.73 $127,855 - $144,533
-2,690 Reduced 1.89%
139,433 $7.48 Billion
Q3 2017

Aug 30, 2024

SELL
$41.15 - $49.22 $257,434 - $307,920
-6,256 Reduced 4.22%
142,123 $6.84 Billion
Q2 2017

Aug 30, 2024

BUY
N/A
108,378
148,379 $6.36 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.